Hesperos: Led operations from inception thru Sept 2019 helping grow the company from 3 employees and <$250k annual revenues to 30 employees > $4.5M and accelerating during that period. Now head of business operations focusing on helping our company get to the next stage. About Hesperos:Hesperos, Inc. is accelerating drug discovery by providing safety and efficacy testing of chemicals and novel therapeutics for the pharmaceutical, cosmetic, and food industries using its patented, Human-on-a-Chip platform. Bringing together biologists, surface chemists, and engineers, our team is producing some of the worlds most advanced organs-on-a-chip platforms. From gene expression to electrophysiology, we recreate key components of organs in an interconnected, functional system. This breakthrough technology enables unprecedented visibility into specific disease states and how the human body will respond to treatment - something that previously required costly animal testing and human trials to determine. As a functional, interconnected, human surrogate, Hesperos’ Human-on-a-Chip is reducing the cost of drug discovery bringing better therapies to patients faster than ever. All while eliminating the need for animal testing and enabling research into rare diseases previously considered untreatable.Hula - Head - Research software startup that we shut down 2015 - 2016 . R.I.P. in short: right problem, wrong(over-built) solution. Plasmonics - COO - Jan. 2013 - Jan. 2015, Helped grow company from 4 to 13 employees while increasing annual revenue 300% to $1.5M in 2013. Plasmonics develops next-generation infrared systems and nanotechnology for the Department of Defense. ...